Serina Therapeutics, Inc.
SERBiotechnology
$1.89+15.24%As of Oct 29vs prior close
- Market cap
- $48M
- P/E (TTM)
- –
- From 52W high
- −62.20%
- EPS (YE25)
- -$1.91
- Revenue (YE25)
- $130K
- Net margin
- -14755.38%
- Dividend yield
- 0.00%
Nomior Score
14
Distressed LaggardBottom 4% of the scored universe
Growth57
Quality21
Value39
Momentum21
Resilience10
Growth
−25.73%revenue a year over 8 fiscal years
YE17 $1.4MYE25 $130K
Connections
Revenue to profitYE25
The operating loss was 18478% of revenue, narrower by 11964 pts on a year.
Who owns it
1fund